Skip to main content
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
New — The Peptide Dictionary: 128 terms, explained simply
New guide — NAD+ for Anti-Aging: What the Science Says
New guide — GHK-Cu: the copper peptide for your skin
Not sure where to start? — A 60-second quiz points you to the path that fits your goal
New explainer — Semaglutide: what the research says, made simple
Browse — Peptide guides, made simple
Easy-to-follow guides
Independent reviews
Vetted providers
Free to read

Home / Peptide legality / Wisconsin

Peptide legality · Wisconsin · updated 2026-09-21

Are peptides legal in Wisconsin?

Gray area

Peptides sit in a legal gray zone in Wisconsin, where FDA-approved products are legal by prescription while unapproved research peptides and compounded copies have no lawful human-use pathway.

Legal status overview

Peptides sit in a legal gray zone in Wisconsin. The state regulates peptides under general pharmacy law rather than a peptide-specific statute, applying Wisconsin Statutes Chapter 450 and administrative code chapter Phar 15 alongside the federal FDA compounding framework. FDA-approved products such as Wegovy® (semaglutide) and Zepbound® (tirzepatide) are legal only by prescription through licensed pharmacies, while research peptides like BPC-157 and TB-500 have no approved human-use route. Compounding is allowed only within federal 503A and 503B limits. This is information, not medical or legal advice.

Key points

  • Wisconsin has no statute or administrative rule that names peptides or research chemicals as a distinct legal category, so peptides fall under standard drug and compounding regulation. [2]
  • The Wisconsin Pharmacy Examining Board enforces compounding standards under Wis. Admin. Code chapter Phar 15, which operates alongside federal compounding law. [1]
  • Brand-name GLP-1 products such as Ozempic® (semaglutide) and Mounjaro® (tirzepatide) are legal only as FDA-approved prescription medicines filled through licensed pharmacies. [2]
  • After the FDA declared the semaglutide and tirzepatide shortages resolved, 503A pharmacies may compound only for documented clinical need rather than routine copies. [3]
  • Compounded semaglutide and tirzepatide are not FDA-approved; not a generic; not evaluated by the FDA, and may not be essentially a copy of an available product. [3]
  • Wisconsin does not set its own substantive baseline for what may be compounded; that eligibility baseline is fixed federally under Sections 503A and 503B. [4]
  • BPC-157 and TB-500 remain unapproved and have no lawful human-use dispensing pathway in Wisconsin despite the April 2026 removal of BPC-157 from FDA Category 2. [5]
  • Human growth hormone and somatropin are prescription-only under federal law, which restricts unapproved distribution as a criminal offense under 21 U.S.C. section 333(e). [2]

Compound-by-compound status

BPC-157
Gray area
Unapproved with no USP monograph; removed from FDA 503A Category 2 in April 2026 and recommended for the list in July 2026, but not yet permitted pending final rulemaking. No lawful human-use pathway in Wisconsin today.
GLP-1 class, including Wegovy® (semaglutide) and Zepbound® (tirzepatide)
Restricted
Brand-name products are legal by prescription. Compounded versions are not FDA-approved; not a generic; not evaluated by the FDA, and are limited to documented-need exceptions now that the shortages have ended.
TB-500
Gray area
Unapproved research peptide with no lawful human-use prescribing pathway in Wisconsin.
Growth hormone / somatropin
Restricted
FDA-approved somatropin is prescription-only for approved indications; federal law restricts unapproved distribution.

Frequently asked questions

Are peptides legal in Wisconsin?

Wisconsin has no peptide-specific law. FDA-approved peptide medications are legal with a valid prescription, while unapproved research peptides such as BPC-157 and TB-500 have no lawful human-use pathway. This is information, not advice.

Can pharmacies compound semaglutide in Wisconsin?

Since the FDA declared the shortage resolved, 503A pharmacies may compound only for documented clinical reasons such as an allergy to an inactive ingredient. Compounded semaglutide is not FDA-approved; not a generic; not evaluated by the FDA.

What rule governs compounding in Wisconsin?

Pharmaceutical compounding is codified in Wis. Admin. Code chapter Phar 15, enforced by the Wisconsin Pharmacy Examining Board, and it operates alongside the federal 503A and 503B framework.

Is BPC-157 legal in Wisconsin?

BPC-157 is unapproved and sits in a federal gray zone. It was removed from FDA Category 2 in April 2026 and recommended for the compounding list in July 2026, but it is not yet permitted and has no lawful human-use pathway in Wisconsin.

Do I need a prescriber license to order compounded medications?

Yes. An active prescribing license recognized by the Wisconsin Pharmacy Examining Board is required to order compounded medications, and the state supports telehealth prescribing statewide.

General information based on the sourced research above, not legal advice. For a specific situation in Wisconsin, consult a licensed attorney familiar with pharmaceutical law.